State of Wisconsin Investment Board
LGND icon

State of Wisconsin Investment Board’s Ligand Pharmaceuticals LGND Stock Holding History

State of Wisconsin Investment Board’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.68M Buy
13,433
+2,278
+20% +$451K 0.01% 1289
2025
Q4 		$2.11M Sell
11,155
-228
-2% -$43.8K ﹤0.01% 1390
2025
Q3 		$2.02M Buy
11,383
+295
+3% +$43.9K ﹤0.01% 1360
2025
Q2 		$1.26M Sell
11,088
-204
-2% -$21.8K ﹤0.01% 1490
2025
Q1 		$1.19M Buy
11,292
+276
+3% +$31.2K ﹤0.01% 1423
2024
Q4 		$1.18M Sell
11,016
-17,534
-61% -$1.98M ﹤0.01% 1459
2024
Q3 		$2.86M Sell
28,550
-6,182
-18% -$622K 0.01% 1176
2024
Q2 		$2.93M Sell
34,732
-2,263
-6% -$180K 0.01% 1143
2024
Q1 		$2.7M Buy
36,995
+23,805
+180% +$1.76M 0.01% 1154
2023
Q4 		$942K Sell
13,190
-110
-0.8% -$6.49K ﹤0.01% 1409
2023
Q3 		$797K Sell
13,300
-604
-4% -$39.8K ﹤0.01% 1482
2023
Q2 		$1M Sell
13,904
-847
-6% -$63.6K ﹤0.01% 1454
2023
Q1 		$1.09M Sell
14,751
-1,654
-10% -$118K ﹤0.01% 1452
2022
Q4 		$1.1M Sell
16,405
-10,750
-40% -$699K ﹤0.01% 1461
2022
Q3 		$1.46M Sell
27,155
-1,813
-6% -$107K ﹤0.01% 1423
2022
Q2 		$1.61M Sell
28,968
-2,130
-7% -$121K ﹤0.01% 1425
2022
Q1 		$2.18M Sell
31,098
-3,527
-10% -$256K ﹤0.01% 1472
2021
Q4 		$3.34M Buy
34,625
+3,527
+11% +$326K 0.01% 1149
2021
Q3 		$2.7M Hold
31,098
– – 0.01% 1217
2021
Q2 		$2.54M Hold
31,098
– – 0.01% 1231
2021
Q1 		$2.96M Sell
31,098
-1,764
-5% -$167K 0.01% 1160
2020
Q4 		$2.04M Sell
32,862
-4,167
-11% -$238K ﹤0.01% 1197
2020
Q3 		$2.2M Hold
37,029
– – 0.01% 1146
2020
Q2 		$2.58M Sell
37,029
-5,290
-13% -$335K 0.01% 1081
2020
Q1 		$1.92M Sell
42,319
-6,412
-13% -$363K 0.01% 1071
2019
Q4 		$3.17M Hold
48,731
– – 0.01% 1051
2019
Q3 		$3.03M Hold
48,731
– – 0.01% 938
2019
Q2 		$3.47M Buy
48,731
+3,045
+7% +$224K 0.01% 909
2019
Q1 		$3.58M Buy
45,686
+11,061
+32% +$838K 0.01% 890
2018
Q4 		$2.93M Buy
34,625
+481
+1% +$51.3K 0.01% 896
2018
Q3 		$5.85M Hold
34,144
– – 0.02% 838
2018
Q2 		$4.41M Buy
34,144
+1,603
+5% +$179K 0.01% 896
2018
Q1 		$3.35M Hold
32,541
– – 0.01% 914
2017
Q4 		$2.78M Buy
32,541
+8,496
+35% +$736K 0.01% 941
2017
Q3 		$2.04M Hold
24,045
– – 0.01% 962
2017
Q2 		$1.82M Buy
+24,045
New +$1.68M 0.01% 963

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State of Wisconsin Investment Board's LGND Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Ligand Pharmaceuticals (LGND) stake by 20% in Q1 2026, buying an estimated $451K and bringing the position to 13,433 shares worth $2.68M. The position accounts for 0.01% of the portfolio, ranked #1289.

State of Wisconsin Investment Board first reported a position in LGND in Q2 2017 and has held it in 36 quarters since. The position peaked at $5.85M in Q3 2018. 358 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • State of Wisconsin Investment Board held 13,433 shares of Ligand Pharmaceuticals worth $2.68M as of Q1 2026.
  • State of Wisconsin Investment Board bought 2,278 Ligand Pharmaceuticals shares in Q1 2026, an estimated $451K.
  • Ligand Pharmaceuticals made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1289 holding.
  • State of Wisconsin Investment Board first reported a position in Ligand Pharmaceuticals in Q2 2017 and has held it in 36 quarters since.
  • State of Wisconsin Investment Board's Ligand Pharmaceuticals position peaked at $5.85M in Q3 2018.
  • 358 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.